Princeton Capital Management Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$4.96M Buy
146,312
+36,018
+33% +$1.16M 2.51% 15
2017
Q2
$3.52M Sell
110,294
-1,525
-1% -$48.1K 2.22% 17
2017
Q1
$3.63M Buy
111,819
+17,222
+18% +$543K 2.29% 19
2016
Q4
$2.92M Buy
94,597
+2,841
+3% +$86.7K 1.94% 21
2016
Q3
$2.95M Sell
91,756
-2,826
-3% -$94.5K 1.93% 23
2016
Q2
$3.16M Buy
94,582
+12,139
+15% +$387K 2.18% 19
2016
Q1
$2.32M Buy
+82,443
New +$2.35M 1.61% 26

Other funds holding PFE

Princeton Capital Management Inc's PFE Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Pfizer (PFE) stake by 33% in Q3 2017, buying an estimated $1.16M and bringing the position to 146,312 shares worth $4.96M. The position accounts for 2.51% of the portfolio, ranked #15.

Princeton Capital Management Inc first reported a position in PFE in Q1 2016 and has held it in 7 quarters since. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Princeton Capital Management Inc held 146,312 shares of Pfizer worth $4.96M as of Q3 2017.
  • Princeton Capital Management Inc bought 36,018 Pfizer shares in Q3 2017, an estimated $1.16M.
  • Pfizer made up 2.51% of Princeton Capital Management Inc's portfolio in Q3 2017, its #15 holding.
  • Princeton Capital Management Inc first reported a position in Pfizer in Q1 2016 and has held it in 7 quarters since.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.